与VRK1变异相关的CMT2和远端遗传运动神经病变:病例系列
Sasha A Živković1, Richard J Nowak2, Daniel DiCapua2
1Department of Neurology, Yale University School of Medicine, New Haven, CT, USA; CMT Program at Yale University, Department of Neurology, Yale University, New Haven, CT, USA.
Neuromuscular disorders : NMD
|December 18, 2024
概括
与疫苗相关的基因酶1 (VRK1) 基因变异与罕见的神经肌肉疾病有关,如夏科特-玛丽-图斯病 (CMT2) 和远端遗传性运动神经病变 (dHMN). 这项研究详细介绍了三个病例,扩大了VRK1相关疾病的已知临床谱.
科学领域:
- 遗传学和分子生物学
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 轴突Charcot-Marie-Tooth病 (CMT2) 和远端遗传运动神经病变 (dHMN) 涉及调节轴突运输,RNA代谢,线粒体动力学和DNA修复的基因.
- VRK1 (疫苗相关激酶1) 是一种激酶,对RNA处理和DNA损伤反应至关重要,已知与神经发育和神经肌肉疾病有关.
相关概念视频
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


